PDCD1LG2 and lung carcinoma: Moreover, anti‐PD‐1 antibody has been already known to provide an optimal blockade of PD‐L1 and PD‐L2, and some reports have shown that the expression of PD‐L2 may be a potential prognostic marker in lung cancer.13, 14